Search results

Richmond Research Institute asks the question, 'Can a second booster dose be delayed in patients who have COVID-19?'

In the UK, two vaccines (BNT162b2-mRNA produced by Pfizer, and ChAdOx-1-S produced by Oxford-AstraZeneca) have been licensed to date, and their administration is prioritised according to individual risk.

COVID-19 Testing - Richmond Research Institute

We have also continued to test for antibodies to both infection and vaccine. By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity may last in each person.

Home video

Do post-COVID-19 patients need a second dose of vaccine? Individuals who were previously infected produced significantly more antibodies, more rapidly. This data could inform prioritisation of vaccine administration. COVID-19 Testing.

Home - Richmond Research Institute

This information could inform the prioritisation of vaccine administration. Watch the video below to learn more.

We work with partners at the following organisations: 

richmond research institute

We have a track record in conducting clinical research.


We present our scientific findings at meetings.


Our academic research helps improve lives and strengthens scientific insights.